What is the price of Brivaracetam in 2026? Market reference

Brivaracetam is an anti-epileptic drug mainly used to treat partial seizures in adults and children with epilepsy over 1 month of age. The drug was developed and produced by UCB Pharma, a Belgian pharmaceutical company, and is currently sold in multiple markets around the world, including the United States, Europe and other regions. However, in the Chinese market, Brivaracetam, as the original drug, has not yet been officially launched, and domestic patients are temporarily unable to purchase the drug directly through formal channels.

Currently, if patients need to purchase Brivaracetam, they usually choose to purchase it through overseas drug purchase channels. The price of Brivaracetam in the European market is relatively stable, and the package price of 50mg*60 tablets is about more than 4,000 yuan. Due to exchange rate fluctuations, the specific price will fluctuate, but you can refer to this range for the approximate price range. When overseas patients purchase Brivaracetam, they usually need to pay a certain postage fee, which varies depending on the country and region. In addition, when purchasing drugs, you need to pay attention to factors such as import procedures, customs regulations, and possible tariffs.

It is important to note that there is currently no generic version of Brivaracetam on the market, which makes Brivaracetam more expensive and patients need to bear higher treatment costs. The high price of brivaracetam may impose a financial burden on some epilepsy patients who require long-term treatment. Therefore, some patients may choose to find other anti-epileptic drugs as alternatives within the scope of medical insurance policies.

Generally speaking, the price of brivaracetam is relatively high, which is mainly affected by the pricing of original drugs and import policies. Despite this, its effectiveness in antiepileptic treatment is evident and it remains an important option for the treatment of patients with refractory partial epilepsy.

Reference materials:https://www.briviact.com/